These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32549544)

  • 1. Biological and clinical significance of T helper 17 cell deficiency: insight into monogenic defects.
    Anka AU; Abdullahi IN; Umar K; Bello ZM; Mohammed M; Gachpaz Sarkhiz S; Abubakar NK; Alsabbagh M; Kamali AN; Azizi G
    Eur Ann Allergy Clin Immunol; 2021 Jul; 53(4):149-160. PubMed ID: 32549544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dedicator of cytokinesis 8 regulates signal transducer and activator of transcription 3 activation and promotes T
    Keles S; Charbonnier LM; Kabaleeswaran V; Reisli I; Genel F; Gulez N; Al-Herz W; Ramesh N; Perez-Atayde A; Karaca NE; Kutukculer N; Wu H; Geha RS; Chatila TA
    J Allergy Clin Immunol; 2016 Nov; 138(5):1384-1394.e2. PubMed ID: 27350570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gain-of-function STAT1 mutations impair STAT3 activity in patients with chronic mucocutaneous candidiasis (CMC).
    Zheng J; van de Veerdonk FL; Crossland KL; Smeekens SP; Chan CM; Al Shehri T; Abinun M; Gennery AR; Mann J; Lendrem DW; Netea MG; Rowan AD; Lilic D
    Eur J Immunol; 2015 Oct; 45(10):2834-46. PubMed ID: 26255980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HDAC inhibitors modulate innate immune responses to micro-organisms relevant to chronic mucocutaneous candidiasis.
    Rösler B; Wang X; Keating ST; Joosten LAB; Netea MG; van de Veerdonk FL
    Clin Exp Immunol; 2018 Nov; 194(2):205-219. PubMed ID: 30069986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy and other primary immunodeficiency diseases help to resolve the nature of protective immunity against chronic mucocutaneous candidiasis.
    Kisand K; Peterson P
    Curr Opin Pediatr; 2013 Dec; 25(6):715-21. PubMed ID: 24240291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic mucocutaneous candidiasis: characterization of a family with STAT-1 gain-of-function and development of an ex-vivo assay for Th17 deficiency of diagnostic utility.
    Dhalla F; Fox H; Davenport EE; Sadler R; Anzilotti C; van Schouwenburg PA; Ferry B; Chapel H; Knight JC; Patel SY
    Clin Exp Immunol; 2016 May; 184(2):216-27. PubMed ID: 26621323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TH17 deficiency in human disease.
    McDonald DR
    J Allergy Clin Immunol; 2012 Jun; 129(6):1429-35; quiz 1436-7. PubMed ID: 22554706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dedicator of cytokinesis 8-deficient CD4
    Tangye SG; Pillay B; Randall KL; Avery DT; Phan TG; Gray P; Ziegler JB; Smart JM; Peake J; Arkwright PD; Hambleton S; Orange J; Goodnow CC; Uzel G; Casanova JL; Lugo Reyes SO; Freeman AF; Su HC; Ma CS
    J Allergy Clin Immunol; 2017 Mar; 139(3):933-949. PubMed ID: 27554822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of Ruxolitinib in a Child with Chronic Mucocutaneous Candidiasis Caused by a Novel STAT1 Gain-of-Function Mutation.
    Bloomfield M; Kanderová V; Paračková Z; Vrabcová P; Svatoň M; Froňková E; Fejtková M; Zachová R; Rataj M; Zentsová I; Milota T; Klocperk A; Kalina T; Šedivá A
    J Clin Immunol; 2018 Jul; 38(5):589-601. PubMed ID: 29934865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defective trained immunity in patients with STAT-1-dependent chronic mucocutaneaous candidiasis.
    Ifrim DC; Quintin J; Meerstein-Kessel L; Plantinga TS; Joosten LA; van der Meer JW; van de Veerdonk FL; Netea MG
    Clin Exp Immunol; 2015 Sep; 181(3):434-40. PubMed ID: 25880788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic mucocutaneous candidiasis due to gain-of-function mutation in STAT1.
    Carey B; Lambourne J; Porter S; Hodgson T
    Oral Dis; 2019 Apr; 25(3):684-692. PubMed ID: 29702748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional analysis of two STAT1 gain-of-function mutations in two Iranian families with autosomal dominant chronic mucocutaneous candidiasis.
    Ostadi V; Sherkat R; Migaud M; Modaressadeghi SM; Casanova JL; Puel A; Nekooie-Marnany N; Ganjalikhani-Hakemi M
    Med Mycol; 2021 Feb; 59(2):180-188. PubMed ID: 32526033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ruxolitinib reverses dysregulated T helper cell responses and controls autoimmunity caused by a novel signal transducer and activator of transcription 1 (STAT1) gain-of-function mutation.
    Weinacht KG; Charbonnier LM; Alroqi F; Plant A; Qiao Q; Wu H; Ma C; Torgerson TR; Rosenzweig SD; Fleisher TA; Notarangelo LD; Hanson IC; Forbes LR; Chatila TA
    J Allergy Clin Immunol; 2017 May; 139(5):1629-1640.e2. PubMed ID: 28139313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Evolving View of IL-17-Mediated Immunity in Defense Against Mucocutaneous Candidiasis in Humans.
    Soltész B; Tóth B; Sarkadi AK; Erdős M; Maródi L
    Int Rev Immunol; 2015; 34(4):348-63. PubMed ID: 26154078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis.
    van de Veerdonk FL; Plantinga TS; Hoischen A; Smeekens SP; Joosten LA; Gilissen C; Arts P; Rosentul DC; Carmichael AJ; Smits-van der Graaf CA; Kullberg BJ; van der Meer JW; Lilic D; Veltman JA; Netea MG
    N Engl J Med; 2011 Jul; 365(1):54-61. PubMed ID: 21714643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines.
    Kisand K; Bøe Wolff AS; Podkrajsek KT; Tserel L; Link M; Kisand KV; Ersvaer E; Perheentupa J; Erichsen MM; Bratanic N; Meloni A; Cetani F; Perniola R; Ergun-Longmire B; Maclaren N; Krohn KJ; Pura M; Schalke B; Ströbel P; Leite MI; Battelino T; Husebye ES; Peterson P; Willcox N; Meager A
    J Exp Med; 2010 Feb; 207(2):299-308. PubMed ID: 20123959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment options for chronic mucocutaneous candidiasis.
    van de Veerdonk FL; Netea MG
    J Infect; 2016 Jul; 72 Suppl():S56-60. PubMed ID: 27161991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [CMCD: Chronic Mucocutaneous Candidiasis Disease].
    Okada S
    Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(2):109-117. PubMed ID: 28603201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STAT1 Gain-of-Function and Dominant Negative STAT3 Mutations Impair IL-17 and IL-22 Immunity Associated with CMC.
    Hiller J; Hagl B; Effner R; Puel A; Schaller M; Mascher B; Eyerich S; Eyerich K; Jansson AF; Ring J; Casanova JL; Renner ED; Traidl-Hoffmann C
    J Invest Dermatol; 2018 Mar; 138(3):711-714. PubMed ID: 29054602
    [No Abstract]   [Full Text] [Related]  

  • 20. New host defense mechanisms against Candida species clarify the basis of clinical phenotypes.
    Hanna S; Etzioni A
    J Allergy Clin Immunol; 2011 Jun; 127(6):1433-7. PubMed ID: 21497889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.